These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19004405)

  • 1. Decreased maternal serum inhibin-A in pregestational diabetic women: implication for adjustment.
    Eddib A; Solimani N; Rodgers B; Yeh J
    J Reprod Med; 2008 Oct; 53(10):785-8. PubMed ID: 19004405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
    Wald NJ; Watt HC; George L
    Prenat Diagn; 1996 Oct; 16(10):923-6. PubMed ID: 8938061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
    Sancken U; Bartels I
    Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hospitalization, type of obstetrical clinic and anamnestic risk profile of pregnant women with pregestational diabetes mellitus--results of the perinatal registry of Lower Saxony, Germany].
    Günter HH; Scharf A; Tzialidou I; Hillemanns P; Wenzlaff P; Maul H
    Zentralbl Gynakol; 2006 Dec; 128(6):341-6. PubMed ID: 17213973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum inhibin A levels in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome.
    Maymon R; Sehmi IK; Herman A; Jones RG; Sherman D; Cuckle H
    Prenat Diagn; 2000 Jan; 20(1):12-6. PubMed ID: 10701844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester levels of inhibins and activin A in normal and failing pregnancies.
    Wallace EM; Marjono B; Tyzack K; Tong S
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):484-90. PubMed ID: 15049964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of serum AGE levels in diabetic mothers with adverse fetal outcome.
    Guosheng L; Hongmei S; Chuan N; Haiying L; Xiaopeng Z; Xianqiong L
    J Perinatol; 2009 Jul; 29(7):483-8. PubMed ID: 19279648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular complications are associated with low levels of maternal sE-selectin and sVCAM-1 in pregnancy complicated with pregestational diabetes mellitus.
    Zawiejska A; Wender-Ozegowska E; Brazert J
    Diabetes Res Clin Pract; 2010 May; 88(2):164-70. PubMed ID: 20129688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
    Spencer K; Cowans NJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First trimester serum inhibin A in normal pregnant women.
    Phupong V; Hanprasertpong T; Honsawek S
    Arch Gynecol Obstet; 2008 Apr; 277(4):307-10. PubMed ID: 17957376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midtrimester maternal serum inhibin A levels after multifetal pregnancy reduction.
    Chen HJ; Huang LW; Lin YH; Seow KM; Hsieh BC; Hwang JL; Tzeng CR
    Prenat Diagn; 2007 May; 27(5):431-4. PubMed ID: 17295349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of congenital anomalies detected during antenatal serum screening in women with pregestational diabetes.
    Ray JG; Vermeulen MJ; Meier C; Wyatt PR
    QJM; 2004 Oct; 97(10):651-3. PubMed ID: 15367735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of maternal ghrelin and leptin in healthy mothers and mothers with Type 1 diabetes.
    Kos K; Syn WK; Lewandowski KC; Bennett J; Nwokolo CU; O'Hare JP; Randeva H
    Diabet Med; 2008 Dec; 25(12):1400-5. PubMed ID: 19046237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of glucose control in diabetic pregnancy to fetal cholesterol homeostasis.
    Gordon Y; Patterson TM; Parker CR
    J Matern Fetal Neonatal Med; 2009 Jan; 22(1):8-12. PubMed ID: 19085625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics.
    Fang YM; MacKeen D; Egan JF; Zelop CM
    J Matern Fetal Neonatal Med; 2009 Mar; 22(3):249-53. PubMed ID: 19330710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum inhibin-A in pregnancies complicated by insulin dependent diabetes mellitus.
    Wallace EM; Crossley JA; Ritoe SC; Groome NP; Aitken DA
    Br J Obstet Gynaecol; 1997 Aug; 104(8):946-8. PubMed ID: 9255088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum chromium and gestational diabetes.
    Woods SE; Ghodsi V; Engel A; Miller J; James S
    J Am Board Fam Med; 2008; 21(2):153-7. PubMed ID: 18343864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of NHS maternity care for women with multiple pregnancy compared with high-risk and low-risk singleton pregnancy.
    Mistry H; Dowie R; Young TA; Gardiner HM;
    BJOG; 2007 Sep; 114(9):1104-12. PubMed ID: 17655730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum alpha-fetoprotein values in type 1 and type 2 diabetic patients.
    Thornburg LL; Knight KM; Peterson CJ; McCall KB; Mooney RA; Pressman EK
    Am J Obstet Gynecol; 2008 Aug; 199(2):135.e1-5. PubMed ID: 18455133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of maternal glycemia on fetal heart rate in pregnancies complicated by pregestational diabetes mellitus.
    Costa VN; Nomura RM; Reynolds KS; Miyadahira S; Zugaib M
    Eur J Obstet Gynecol Reprod Biol; 2009 Mar; 143(1):14-7. PubMed ID: 19178991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.